1. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial – update of patient characteristics and study timeline after interim analysis. (14th October 2021) Authors: Poli, S; Meissner, C; Baezner, H J; Kraft, A; Hillenbrand, F; Hobohm, C; Liman, J; Wachter, R; Kimmig, H; Huber, R; Lindner, A; Althaus, K; Gawaz, M; Ziemann, U; Geisler, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial – update of patient characteristics and study timeline after interim analysis. (14th October 2021) Authors: Poli, S; Meissner, C; Baezner, H J; Kraft, A; Hillenbrand, F; Hobohm, C; Liman, J; Wachter, R; Kimmig, H; Huber, R; Lindner, A; Althaus, K; Gawaz, M; Ziemann, U; Geisler, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗